While the N-glycosylation of IgM has been characterized previously in healthy pooled human serum, during cancer [35, 43–45], and in recombinant IgM [34, 46], this is the first characterization of the IgM N-glycosylation profile isolated from humans infected with an acute viral disease. This evidence concerns the gene CD40LG and cancer.